DOCSLIB.ORG

Supplementary Table 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table 1 Supplemental Table 1. List of known genes affected by radiation as detected by microarray analysis of polysome-bound RNA and total cellular RNA. U87 cell were irradiated with 7 Gy and collected for microarray analyses 6h later. Polysome-bound RNA UniGene # Gene Description Fold Change (log 2) Hs.429294 ABCA1 ATP-binding cassette, sub-family A (ABC1), member 1 1.5829 Hs.471277 ACADL Acyl-Coenzyme A dehydrogenase, long chain 1.2587 Hs.471461 ACSL3 Acyl-CoA synthetase long-chain family member 3 1.2404 Hs.268785 ACSL4 Acyl-CoA synthetase long-chain family member 4 1.5611 Hs.14945 ACSL6 Acyl-CoA synthetase long-chain family member 6 1.5067 Hs.393201 ACTR2 ARP2 actin-related protein 2 homolog (yeast) 1.4219 Hs.433512 ACTR3 ARP3 actin-related protein 3 homolog (yeast) 1.2404 Hs.150402 ACVR1 activin A receptor, type I=Ser/Thr protein kinase receptor R1 1.2864 Hs.438918 ACVR1B Activin A receptor, type IB 1.0827 Hs.127930 ADAM18 A disintegrin and metalloproteinase domain 18 1.0261 Hs.370287 ADAM23 A disintegrin and metalloproteinase domain 23 1.226 Hs.2442 ADAM9 A disintegrin and metalloproteinase domain 9 (meltrin gamma) 1.6771 Hs.151435 ADAMTS3 A disintegrin-like and metalloprotease (reprolysin type) with 1.3683 thrombospondin type 1 motif, 3 Hs.498313 ADSS Adenylosuccinate synthase 1.1344 Hs.515053 AES Amino-terminal enhancer of split 1.518 Hs.75823 AF1Q ALL1-fused gene from chromosome 1q 1.879 Hs.904 AGL Amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (glycogen 1.2491 debranching enzyme, glycogen storage disease type III) Hs.530009 AGR2 Anterior gradient 2 homolog (Xenopus laevis) 1.0291 Hs.488945 AIP1 Atrophin-1 interacting protein 1 2.309 Hs.105105 AKAP11 A kinase (PRKA) anchor protein 11 1.2621 Hs.459211 AKAP13 A kinase (PRKA) anchor protein 13 1.1679 Hs.98397 AKAP3 A kinase (PRKA) anchor protein 3 1.1621 Hs.515406 AKT2 V-akt murine thymoma viral oncogene homolog 2 1.3025 Hs.499886 ALDH3A2 Aldehyde dehydrogenase 3 family, member A2 1.4854 Hs.159118 AMD1 Adenosylmethionine decarboxylase 1 1.2007 Hs.514463 AMY2A Amylase, alpha 2A; pancreatic 1.0363 Hs.480876 ANAPC10 Anaphase promoting complex subunit 10 1.6952 Hs.369675 ANGPT1 Angiopoietin 1 1.6068 Hs.448589 ANKRD1 Cytokine inducible nuclear protein=cardiac ankyrin repeat protein 1.0246 Hs.494173 ANXA1 Annexin A1 1.5475 Hs.181107 ANXA13 Annexin A13 1.1382 Hs.406191 AP3S1 Adaptor-related protein complex 3, sigma 1 subunit 2.169 Hs.486063 APG5L APG5 autophagy 5-like (S. cerevisiae) 1.2181 Hs.560 APOBEC1 Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 1.4838 Hs.227457 APOBEC2 Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 1.5868 Hs.130730 AQP2 Aquaporin 2 (collecting duct) 1.1132 Hs.234642 AQP3 Aquaporin 3 1.2715 Hs.496240 AR Androgen receptor (dihydrotestosterone receptor; testicular 1.3776 feminization; spinal and bulbar muscular atrophy; Kennedy disease) Hs.62578 ARFGEF2 ADP-ribosylation factor guanine nucleotide-exchange factor 2 1.6478 (brefeldin A-inhibited) Hs.416089 ARFIP1 ADP-ribosylation factor interacting protein 1 (arfaptin 1) 1.7266 Hs.440934 ARG1 Arginase, liver 1.1512 Hs.6838 ARHE Rho family GTPase 3 1.7539 Hs.435291 ARHGAP6 Rho GTPase activating protein 6 1.5181 Hs.161000 ARID4A AT rich interactive domain 4A (RBP1-like) 1.5365 Hs.372616 ARL1 ADP-ribosylation factor-like 1 1.0695 Hs.518060 ARL6IP5 ADP-ribosylation-like factor 6 interacting protein 5 1.2676 Hs.486031 ASCC3 DJ467N11.1 protein 1.289 Hs.446684 ASE-1 CD3-epsilon-associated protein; antisense to ERCC-1 1.5855 Hs.489037 ASK Activator of S phase kinase 1.1802 Hs.546238 ATP5E ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon 2.1574 1 subunit Hs.514870 ATP5F1 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, 1.3954 isoform 1 Hs.429 ATP5G3 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c 1.1623 (subunit 9) isoform 3 Hs.85539 ATP5I ATP synthase, H+ transporting, mitochondrial F0 complex, subunit e 1.1542 Hs.246310 ATP5J ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6 1.5751 Hs.216623 ATP8B1 ATPase, Class I, type 8B, member 1 2.747 Hs.465475 ATP9B ATPase, Class II, type 9B 1.2243 Hs.533526 ATRX Alpha thalassemia/mental retardation syndrome X-linked (RAD54 1.2137 homolog, S. cerevisiae) Hs.55220 BAG2 BCL2-associated athanogene 2 1.2472 Hs.13261 BAI3 Brain-specific angiogenesis inhibitor 3 1.6211 Hs.169441 BAIAP1 BAI1-associated protein 1 1.2942 Hs.470369 BAZ2B Bromodomain adjacent to zinc finger domain, 2B 1.3289 Hs.22960 BCAS2 Breast carcinoma amplified sequence 2 1.0667 Hs.513520 BCKDK Branched chain ketoacid dehydrogenase kinase 1.227 Hs.489132 BET1 BET1 homolog (S. cerevisiae) 1.0591 Hs.27372 BMX BMX non-receptor tyrosine kinase 1.8336 Hs.10136 BPHL Biphenyl hydrolase-like (serine hydrolase; breast epithelial mucin- 1.1572 associated antigen) Hs.127950 BRD1 Bromodomain containing 1 1.6437 Hs.500526 BTAF1 BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 1.1791 170kDa (Mot1 homolog, S. cerevisiae) Hs.499833 C10orf74 Chromosome 10 open reading frame 74 1.5968 Hs.72925 C11orf13 Chromosome 11 open reading frame 13 1.2252 Hs.277517 C11orf2 Chromosome 11 open reading frame2 1.3659 Hs.441926 C13orf24 Chromosome 13 open reading frame 24 1.0308 Hs.464697 C18orf1 Chromosome 18 open reading frame 1 1.3068 Hs.525462 C1orf41 Chromosome 1 open reading frame 41 1.6556 Hs.110196 C1orf42 Chromosome 1 open reading frame 42 1.0806 Hs.204559 C1orf9 Chromosome 1 open reading frame 9 1.1792 Hs.369284 C20orf6 Chromosome 20 open reading frame 6 1.5443 Hs.303808 C2orf3 Chromosome 2 open reading frame 3 1.1054 Hs.303808 C2orf3 Chromosome 2 open reading frame 3 1.2779 Hs.485588 C6orf142 Chromosome 6 open reading frame 142 1.0082 Hs.436445 C8orf1 Chromosome 8 open reading frame 1 2.1074 Hs.23118 CA1 Carbonic anhydrase I 1.2829 Hs.23118 CA1 Carbonic anhydrase I 1.4759 Hs.82129 CA3 Carbonic anhydrase III, muscle specific 1.4363 Hs.100322 CA6 Carbonic anhydrase VI 1.0999 Hs.408449 CACNA1A Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit 1.2464 Hs.508524 CACYBP Calcyclin binding protein 1.1441 Hs.489127 CALCR Calcitonin receptor 1.1172 Hs.468442 CALM2 Calmodulin 2 (phosphorylase kinase, delta) 1.0372 Hs.495984 CASK Calcium/calmodulin-dependent serine protein kinase (MAGUK family) 1.6077 Hs.9216 CASP7 CASPASE-7=mch3=Ice-lap3 1.0862 Hs.430124 CASP8 CASPASE-8=Mch5=FLICE=MACH-alpha-1 1.2974 Hs.546332 CASP8AP2 CASP8 associated protein 2 1.1608 Hs.435615 CASR Calcium-sensing receptor (hypocalciuric hypercalcemia 1, severe 1.4537 neonatal hyperparathyroidism) Hs.440961 CAST Calpastatin 1.21 Hs.502302 CAT Catalase 1.4323 Hs.504096 CBL Cas-Br-M (murine) ecotropic retroviral transforming sequence 1.1503 Hs.436242 CCDC7 Coiled-coil domain containing 7 1.0148 Hs.303649 CCL2 MCP-1=MCAF=small inducible cytokine A2=JE=chemokine 1.4226 Hs.85137 CCNA2 cyclin A2 1.5948 Hs.430646 CCNC Cyclin C 1.2999 Hs.13291 CCNG2 Cyclin G2 1.9074 Hs.279906 CCNT1 cyclin T 1.0107 Hs.292754 CCNT2 Cyclin T2 1.2751 Hs.491494 CCT3 Chaperonin containing TCP1, subunit 3 (gamma) 1.0939 Hs.369661 CD226 adhesion molecule DNAM-1 1.2611 2 Hs.485518 CD2AP CD2-associated protein 1.4568 Hs.75626 CD58 CD58=LFA-3 1.2493 Hs.334562 CDC2 Cell division cycle 2, G1 to S and G2 to M 1.8611 Hs.428147 CDC40 Cell division cycle 40 homolog (yeast) 1.1995 Hs.116471 CDH11 Cadherin 11, type 2, OB-cadherin (osteoblast) 1.8221 Hs.436040 CDH13 Cadherin 13, H-cadherin (heart) 1.0814 Hs.433201 CDK2AP1 CDK2-associated protein 1=putative oral tumor suppressor protein 1.8285 (doc-1) Hs.397734 CDK8 Cdk8=Cyclin-dependent kinase 8 1.0491 Hs.238990 CDKN1B Cyclin-dependent kinase inhibitor 1B (p27, Kip1) 1.5503 Hs.444430 CDS1 CDP-diacylglycerol synthetase 1.2014 Hs.499222 CES1 Carboxylesterase 1 (monocyte/macrophage serine esterase 1) 1.6478 Hs.128342 CESK1 T-complex protein 1 1.6808 Hs.528302 CETN3 Centrin, EF-hand protein, 3 (CDC31 homolog, yeast) 1.5159 Hs.161220 CG018 Hypothetical gene CG018 1.1702 Hs.119689 CGA Glycoprotein hormones, alpha polypeptide 1.0744 Hs.444818 CGGBP1 CGG triplet repeat binding protein 1 1.3908 Hs.170129 CHML Choroideremia-like (Rab escort protein 2) 1.2895 Hs.283725 CHODL Chondrolectin 1.328 Hs.293077 CHPT1 Choline phosphotransferase 1 1.1348 Hs.15159 CKLF Chemokine-like factor 1.2894 Hs.889 CLC Charcot-Leyden crystal protein 1.0372 Hs.535985 CLCN5 Chloride channel 5 (nephrolithiasis 2, X-linked, Dent disease) 1.096 Hs.504657 CLECSF6 C-type lectin domain family 4, member A 1.2502 Hs.86368 CLGN Calmegin=putative testis-specific chaperon 1.1779 Hs.54570 CLIC2 Chloride intracellular channel 2 1.1084 Hs.433732 CLK1 CLK-1=CDC-like kinase 1=PITSLRE alpha 1=galactosyltransferase 1.3448 associated protein kinase P58/GTA Hs.311346 CMAS Cytidine monophosphate N-acetylneuraminic acid synthetase 1.1612 Hs.1323 CNGA1 Cyclic nucleotide gated channel alpha 1 1.335 Hs.294603 CNIH Cornichon homolog (Drosophila) 1.4668 Hs.377466 COCH Coch-5B2=similar to chicken collagen XIV=coagulation factor C 1.5431 (Limulus polyphemus homolog); cochlin Hs.520339 COL10A1 Collagen, type X, alpha 1(Schmid metaphyseal chondrodysplasia) 1.0571 Hs.211933 COL13A1 Collagen, type XIII, alpha 1 1.1546 Hs.149809 COL9A1 Collagen, type IX, alpha 1 1.1108 Hs.534383 COX17 COX17 homolog, cytochrome c oxidase assembly protein (yeast) 1.1375 Hs.351875 COX6C Cytochrome c oxidase subunit VIc 1.6452 Hs.430075 COX7C cytochrome c oxidase subunit VIIc 1.6898 Hs.646 CPA3 Carboxypeptidase A3 (mast cell) 1.1095 Hs.191219 CPNE3 Copine III 1.2686 Hs.435675 CPSF2 Cleavage and polyadenylation specific factor
Load more

Recommended publications
  • Comparative Gene Expression Profiling of Stromal Cell Matrices
    ell Res C ea m rc te h S & f o T h l Journal of Tiwari et al., J Stem Cell Res Ther 2013, 3:4 e a r n a r p u DOI: 10.4172/2157-7633.1000152 y o J ISSN: 2157-7633 Stem Cell Research & Therapy Research Article Open Access Comparative Gene Expression Profiling of Stromal Cell Matrices that Support Expansion of Hematopoietic Stem/Progenitor Cells Abhilasha Tiwari1,2, Christophe Lefevre2, Mark A Kirkland2*, Kevin Nicholas2 and Gopal Pande1* 1CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, India 2Deakin University, Waurn Ponds, Geelong, VIC, Australia Abstract The bone marrow microenvironment maintains a stable balance between self-renewal and differentiation of hematopoietic stem/progenitor cells (HSPCs). This microenvironment, also termed the “hematopoietic niche”, is primarily composed of stromal cells and their extracellular matrices (ECM) that jointly regulate HSPC functions. Previously, we have demonstrated that umbilical cord blood derived HSPCs can be maintained and expanded on stromal cell derived acellular matrices that mimic the complexity of the hematopoietic niche. The results indicated that matrices prepared at 20% O2 with osteogenic medium (OGM) were best suited for expanding committed HSPCs, whereas, matrices prepared at 5% O2 without OGM were better for primitive progenitors. Based upon these results we proposed that individual constituents of these matrices could be responsible for regulation of specific HSPC functions. To explore this hypothesis, we have performed comparative transcriptome profiling of these matrix producing cells, which identified differential expression of both known niche regulators, such as Wnt4, Angpt2, Vcam and Cxcl12, as well as genes not previously associated with HSPC regulation, such as Depp.
    [Show full text]
  • Anthropoid Primate–Specific Retroviral Element THE1B Controls Expression of CRH in Placenta and Alters Gestation Length
    SHORT REPORTS Anthropoid primate±specific retroviral element THE1B controls expression of CRH in placenta and alters gestation length 1 1 1 2 Caitlin E. Dunn-FletcherID *, Lisa M. Muglia , Mihaela Pavlicev , Gernot Wolf , Ming- An Sun2, Yueh-Chiang Hu3, Elizabeth Huffman1, Shivani Tumukuntala1, Katri Thiele1, Amrita Mukherjee1, Sandra Zoubovsky1, Xuzhe Zhang1, Kayleigh A. Swaggart1, Katherine Y. Bezold Lamm1, Helen Jones4, Todd S. Macfarlan2, Louis J. Muglia1* a1111111111 1 Division of Human Genetics, Center for Prevention of Preterm Birth, Perinatal Institute, Cincinnati a1111111111 Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, a1111111111 Cincinnati, Ohio, United States of America, 2 The Eunice Kennedy Shriver National Institute of Child Health a1111111111 and Human Development, The National Institutes of Health, Bethesda, Maryland, United States of America, 3 Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Department of a1111111111 Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America, 4 Division of Pediatric Surgery, Cincinnati Children's Hospital Medical Center, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America * [email protected] (CED); [email protected] (LJM) OPEN ACCESS Citation: Dunn-Fletcher CE, Muglia LM, Pavlicev M, Wolf G, Sun M-A, Hu Y-C, et al. (2018) Anthropoid Abstract primate±specific retroviral element THE1B controls expression of CRH in placenta and alters gestation Pregnancy and parturition are intricately regulated to ensure successful reproductive out- length. PLoS Biol 16(9): e2006337. https://doi.org/ comes. However, the factors that control gestational length in humans and other anthropoid 10.1371/journal.pbio.2006337 primates remain poorly defined.
    [Show full text]
  • Anti-SNX18 Polyclonal Antibody (CABT-B1766) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
    Anti-SNX18 polyclonal antibody (CABT-B1766) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Specificity Expected to react with all spliced isoforms. Immunogen Recombinant protein corresponding to human SNX18. Isotype IgG Source/Host Rabbit Species Reactivity Canine, Human Purification Affinity Purfied Conjugate Unconjugated Applications WB, ICC, IP Molecular Weight ~73 kDa observed Format Liquid Concentration Please refer to lot specific datasheet. Size 100 μg Buffer PBS with 0.05% sodium azide. Preservative 0.05% Sodium Azide Storage Stable for 1 year at 2-8°C from date of receipt. BACKGROUND Introduction Sorting nexin-18 (UniProt Q96RF0; also known as SH3 and PX domain-containing protein 3B, Sorting nexin-associated Golgi protein 1) is encoded by the SNX18 (also known as SNAG1, SH3PX2, SH3PXD3B) gene (Gene ID 112574) in human. SNX18, SNX33, and SNX9 constitute a subfamily of sorting nexin (SNX) proteins characterized by a Bin–Amphiphysin–Rvs (BAR) domain that allows dimerization. It also contributes to modulation and shaping of membrane curvature. It also has a Src-homology 3 (SH3) domain that allows interaction with a wide range of proline-rich PXXP motif containing proteins. In addition to mediating endocytosis and intracellular 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved vesicle trafficking, SNX18, SNX33, and SNX9 are also essential for successful completion of the ingression and abscission stages of cytokinesis and for the delivery of a subset of vesicles to the intracellular bridge that connects the two nascent daughter cells during mitosis.
    [Show full text]
  • Dickkopf-1 Promotes Hematopoietic Regeneration Via Direct and Niche-Mediated Mechanisms
    ARTICLES Dickkopf-1 promotes hematopoietic regeneration via direct and niche-mediated mechanisms Heather A Himburg1,7, Phuong L Doan2,7, Mamle Quarmyne1,3, Xiao Yan1,3, Joshua Sasine1, Liman Zhao1, Grace V Hancock4, Jenny Kan1, Katherine A Pohl1, Evelyn Tran1, Nelson J Chao2, Jeffrey R Harris2 & John P Chute1,5,6 The role of osteolineage cells in regulating hematopoietic stem cell (HSC) regeneration following myelosuppression is not well understood. Here we show that deletion of the pro-apoptotic genes Bak and Bax in osterix (Osx, also known as Sp7 transcription factor 7)-expressing cells in mice promotes HSC regeneration and hematopoietic radioprotection following total body irradiation. These mice showed increased bone marrow (BM) levels of the protein dickkopf-1 (Dkk1), which was produced in Osx-expressing BM cells. Treatment of irradiated HSCs with Dkk1 in vitro increased the recovery of both long-term repopulating HSCs and progenitor cells, and systemic administration of Dkk1 to irradiated mice increased hematopoietic recovery and improved survival. Conversely, inducible deletion of one allele of Dkk1 in Osx-expressing cells in adult mice inhibited the recovery of BM stem and progenitor cells and of complete blood counts following irradiation. Dkk1 promoted hematopoietic regeneration via both direct effects on HSCs, in which treatment with Dkk1 decreased the levels of mitochondrial reactive oxygen species and suppressed senescence, and indirect effects on BM endothelial cells, in which treatment with Dkk1 induced epidermal growth factor (EGF) secretion. Accordingly, blockade of the EGF receptor partially abrogated Dkk1-mediated hematopoietic recovery. These data identify Dkk1 as a regulator of hematopoietic regeneration and demonstrate paracrine cross-talk between BM osteolineage cells and endothelial cells in regulating hematopoietic reconstitution following injury.
    [Show full text]
  • Pathway-Based Genome-Wide Association Analysis of Coronary Heart Disease Identifies Biologically Important Gene Sets
    European Journal of Human Genetics (2012) 20, 1168–1173 & 2012 Macmillan Publishers Limited All rights reserved 1018-4813/12 www.nature.com/ejhg ARTICLE Pathway-based genome-wide association analysis of coronary heart disease identifies biologically important gene sets Lisa de las Fuentes1,4, Wei Yang2,4, Victor G Da´vila-Roma´n1 and C Charles Gu*,2,3 Genome-wide association (GWA) studies of complex diseases including coronary heart disease (CHD) challenge investigators attempting to identify relevant genetic variants among hundreds of thousands of markers being tested. A selection strategy based purely on statistical significance will result in many false negative findings after adjustment for multiple testing. Thus, an integrated analysis using information from the learned genetic pathways, molecular functions, and biological processes is desirable. In this study, we applied a customized method, variable set enrichment analysis (VSEA), to the Framingham Heart Study data (404 467 variants, n ¼ 6421) to evaluate enrichment of genetic association in 1395 gene sets for their contribution to CHD. We identified 25 gene sets with nominal Po0.01; at least four sets are previously known for their roles in CHD: vascular genesis (GO:0001570), fatty-acid biosynthetic process (GO:0006633), fatty-acid metabolic process (GO:0006631), and glycerolipid metabolic process (GO:0046486). Although the four gene sets include 170 genes, only three of the genes contain a variant ranked among the top 100 in single-variant association tests of the 404 467 variants tested. Significant enrichment for novel gene sets less known for their importance to CHD were also identified: Rac 1 cell-motility signaling pathway (h_rac1 Pathway, Po0.001) and sulfur amino-acid metabolic process (GO:0000096, Po0.001).
    [Show full text]
  • The Expression of Human Endogenous Retroviruses Is Modulated by the Tat Protein of HIV‐1
    The Expression of Human Endogenous Retroviruses is modulated by the Tat protein of HIV‐1 by Marta Jeannette Gonzalez‐Hernandez A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Immunology) in The University of Michigan 2012 Doctoral Committee Professor David M. Markovitz, Chair Professor Gary Huffnagle Professor Michael J. Imperiale Associate Professor David J. Miller Assistant Professor Akira Ono Assistant Professor Christiane E. Wobus © Marta Jeannette Gonzalez‐Hernandez 2012 For my family and friends, the most fantastic teachers I have ever had. ii Acknowledgements First, and foremost, I would like to thank David Markovitz for his patience and his scientific and mentoring endeavor. My time in the laboratory has been an honor and a pleasure. Special thanks are also due to all the members of the Markovitz laboratory, past and present. It has been a privilege, and a lot of fun, to work near such excellent scientists and friends. You all have a special place in my heart. I would like to thank all the members of my thesis committee for all the valuable advice, help and jokes whenever needed. Our collaborators from the Bioinformatics Core, particularly James Cavalcoli, Fan Meng, Manhong Dai, Maureen Sartor and Gil Omenn gave generous support, technical expertise and scientific insight to a very important part of this project. Thank you. Thanks also go to Mariana Kaplan’s and Akira Ono’s laboratory for help with experimental designs and for being especially generous with time and reagents. iii Table of Contents Dedication ............................................................................................................................ ii Acknowledgements ............................................................................................................. iii List of Figures ...................................................................................................................
    [Show full text]
  • Supporting Online Material
    1 2 3 4 5 6 7 Supplementary Information for 8 9 Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic 10 retinopathy 11 12 *Samuel A. Mills, *Andrew I. Jobling, *Michael A. Dixon, Bang V. Bui, Kirstan A. Vessey, Joanna A. Phipps, 13 Ursula Greferath, Gene Venables, Vickie H.Y. Wong, Connie H.Y. Wong, Zheng He, Flora Hui, James C. 14 Young, Josh Tonc, Elena Ivanova, Botir T. Sagdullaev, Erica L. Fletcher 15 * Joint first authors 16 17 Corresponding author: 18 Prof. Erica L. Fletcher. Department of Anatomy & Neuroscience. The University of Melbourne, Grattan St, 19 Parkville 3010, Victoria, Australia. 20 Email: [email protected] ; Tel: +61-3-8344-3218; Fax: +61-3-9347-5219 21 22 This PDF file includes: 23 24 Supplementary text 25 Figures S1 to S10 26 Tables S1 to S7 27 Legends for Movies S1 to S2 28 SI References 29 30 Other supplementary materials for this manuscript include the following: 31 32 Movies S1 to S2 33 34 35 36 1 1 Supplementary Information Text 2 Materials and Methods 3 Microglial process movement on retinal vessels 4 Dark agouti rats were anaesthetized, injected intraperitoneally with rhodamine B (Sigma-Aldrich) to label blood 5 vessels and retinal explants established as described in the main text. Retinal microglia were labelled with Iba-1 6 and imaging performed on an inverted confocal microscope (Leica SP5). Baseline images were taken for 10 7 minutes, followed by the addition of PBS (10 minutes) and then either fractalkine or fractalkine + candesartan 8 (10 minutes) using concentrations outlined in the main text.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • PROTEOMIC ANALYSIS of HUMAN URINARY EXOSOMES. Patricia
    ABSTRACT Title of Document: PROTEOMIC ANALYSIS OF HUMAN URINARY EXOSOMES. Patricia Amalia Gonzales Mancilla, Ph.D., 2009 Directed By: Associate Professor Nam Sun Wang, Department of Chemical and Biomolecular Engineering Exosomes originate as the internal vesicles of multivesicular bodies (MVBs) in cells. These small vesicles (40-100 nm) have been shown to be secreted by most cell types throughout the body. In the kidney, urinary exosomes are released to the urine by fusion of the outer membrane of the MVBs with the apical plasma membrane of renal tubular epithelia. Exosomes contain apical membrane and cytosolic proteins and can be isolated using differential centrifugation. The analysis of urinary exosomes provides a non- invasive means of acquiring information about the physiological or pathophysiological state of renal cells. The overall objective of this research was to develop methods and knowledge infrastructure for urinary proteomics. We proposed to conduct a proteomic analysis of human urinary exosomes. The first objective was to profile the proteome of human urinary exosomes using liquid chromatography-tandem spectrometry (LC- MS/MS) and specialized software for identification of peptide sequences from fragmentation spectra. We unambiguously identified 1132 proteins. In addition, the phosphoproteome of human urinary exosomes was profiled using the neutral loss scanning acquisition mode of LC-MS/MS. The phosphoproteomic profiling identified 19 phosphorylation sites corresponding to 14 phosphoproteins. The second objective was to analyze urinary exosomes samples isolated from patients with genetic mutations. Polyclonal antibodies were generated to recognize epitopes on the gene products of these genetic mutations, NKCC2 and MRP4. The potential usefulness of urinary exosome analysis was demonstrated using the well-defined renal tubulopathy, Bartter syndrome type I and using the single nucleotide polymorphism in the ABCC4 gene.
    [Show full text]
  • Congenital Disorders of Glycosylation from a Neurological Perspective
    brain sciences Review Congenital Disorders of Glycosylation from a Neurological Perspective Justyna Paprocka 1,* , Aleksandra Jezela-Stanek 2 , Anna Tylki-Szyma´nska 3 and Stephanie Grunewald 4 1 Department of Pediatric Neurology, Faculty of Medical Science in Katowice, Medical University of Silesia, 40-752 Katowice, Poland 2 Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland; [email protected] 3 Department of Pediatrics, Nutrition and Metabolic Diseases, The Children’s Memorial Health Institute, W 04-730 Warsaw, Poland; [email protected] 4 NIHR Biomedical Research Center (BRC), Metabolic Unit, Great Ormond Street Hospital and Institute of Child Health, University College London, London SE1 9RT, UK; [email protected] * Correspondence: [email protected]; Tel.: +48-606-415-888 Abstract: Most plasma proteins, cell membrane proteins and other proteins are glycoproteins with sugar chains attached to the polypeptide-glycans. Glycosylation is the main element of the post- translational transformation of most human proteins. Since glycosylation processes are necessary for many different biological processes, patients present a diverse spectrum of phenotypes and severity of symptoms. The most frequently observed neurological symptoms in congenital disorders of glycosylation (CDG) are: epilepsy, intellectual disability, myopathies, neuropathies and stroke-like episodes. Epilepsy is seen in many CDG subtypes and particularly present in the case of mutations
    [Show full text]
  • Differential Regulation of Proteoglycan 4 Metabolism in Cartilage by IL-1A, IGF-I, and TGF-B1 T
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Osteoarthritis and Cartilage (2008) 16, 90e97 ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved. doi:10.1016/j.joca.2007.05.009 International Cartilage Repair Society Differential regulation of proteoglycan 4 metabolism in cartilage by IL-1a, IGF-I, and TGF-b1 T. A. Schmidt Ph.D., N. S. Gastelum B.S., E. H. Han M.S., G. E. Nugent-Derfus Ph.D., B. L. Schumacher B.S. and R. L. Sah M.D., Sc.D.* Department of Bioengineering and Whitaker Institute of Biomedical Engineering, University of California-San Diego, La Jolla, CA 92093-0412, United States Summary Objectives: To determine (1) if interleukin-1 alpha (IL-1a), insulin like growth factor I (IGF-I), and transforming growth factor-beta 1 (TGF-b1) regulate proteoglycan 4 (PRG4) metabolism in articular cartilage, in terms of chondrocytes expressing PRG4 and PRG4 bound at the articular surface, and (2) if these features of cartilage PRG4 metabolism correlate with its secretion. Methods: Articular cartilage explants were harvested and cultured for 6 days with or without 10% fetal bovine serum (FBS), alone, or with the addition of 10 ng/ml IL-1a, 300 ng/ml IGF-I, or 10 ng/ml TGF-b1. PRG4 expression by chondrocytes in the cartilage disks was assessed by immunohistochemistry (IHC). PRG4 bound to the articular surface of disks was quantified by extraction and enzyme-linked immunosorbent assay (ELISA). PRG4 secreted into culture medium was quantified by ELISA and characterized by Western Blot.
    [Show full text]
  • Predicting Clinical Response to Treatment with a Soluble Tnf-Antagonist Or Tnf, Or a Tnf Receptor Agonist
    (19) TZZ _ __T (11) EP 2 192 197 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 02.06.2010 Bulletin 2010/22 C12Q 1/68 (2006.01) (21) Application number: 08170119.5 (22) Date of filing: 27.11.2008 (84) Designated Contracting States: (72) Inventor: The designation of the inventor has not AT BE BG CH CY CZ DE DK EE ES FI FR GB GR yet been filed HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR (74) Representative: Habets, Winand Designated Extension States: Life Science Patents AL BA MK RS PO Box 5096 6130 PB Sittard (NL) (71) Applicant: Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg 1081 HV Amsterdam (NL) (54) Predicting clinical response to treatment with a soluble tnf-antagonist or tnf, or a tnf receptor agonist (57) The invention relates to methods for predicting a clinical response to a therapy with a soluble TNF antagonist, TNF or a TNF receptor agonist and a kit for use in said methods. EP 2 192 197 A1 Printed by Jouve, 75001 PARIS (FR) EP 2 192 197 A1 Description [0001] The invention relates to methods for predicting a clinical response to a treatment with a soluble TNF antagonist, with TNF or a TNF receptor agonist using expression levels of genes of the Type I INF pathway and a kit for use in said 5 methods. In another aspect, the invention relates to a method for evaluating a pharmacological effect of a treatment with a soluble TNF antagonist, TNF or a TNF receptor agonist.
    [Show full text]